Dynamics-Based Discovery of Novel, Potent Benzoic Acid Derivatives as Orally Bioavailable Selective Estrogen Receptor Degraders for ERα+ Breast Cancer
Authors:
- 31 May 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (11) , 7575-7595
Abstract
The estrogen receptor α (ERα) is identified as an effective target for the treatment of ERα+ breast cancer; thus, discovery of novel selective estrogen receptor degraders (SERDs) are developed as an effective method to overcome the resistance of breast cancer. Herein, the hot-spot residues for protein–ligand interaction between SERDs and ERα are analyzed by molecular dynamic simulation technology, focusing on the hot-spot residues for four series of designed and synthesized SERDs. SAR studies revealed that while the acrylic acid moiety of AZD9496 is scaffold hopping into benzoic acid, compound D24 exhibits potent binding affinity with ERα, good degradation efficacy of ERα, and inhibitory effect against the MCF-7 breast cancer cell line. Besides, D24 also displays good antitumor efficacy in the MCF-7 human breast cancer xenograft model in vivo, favorable pharmacokinetic properties, excellent druggability, and good safety property, making D24 as a promising drug candidate of SERD for further evaluation.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20161050)
- National Natural Science Foundation of China (81573304, 81703342)
- Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX19_1261)
This publication has 52 references indexed in Scilit:
- Recent Advances in the Treatment of Breast CancerFrontiers in Oncology, 2018
- Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesisGenes & Diseases, 2018
- Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatmentPharmacology & Therapeutics, 2018
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challengesMolecular and Cellular Endocrinology, 2015
- The changing role of ER in endocrine resistanceThe Breast, 2015
- Strategies for the discovery and development of therapies for metastatic breast cancerNature Reviews Drug Discovery, 2012
- Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouseLaboratory Animal Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Estrogen Receptors as Therapeutic Targets in Breast CancerCurrent Topics in Medicinal Chemistry, 2006